Some Americans are struggling to get the new COVID-19 vaccine due to high demand, insurance headaches, and supply delays.
The FDA has rejected a nasal spray that would have been the first alternative to injections for treating severe allergic reactions. The agency is calling for more research on repeat doses of the drug epinephrine, which is used to halt anaphylaxis, a potentially life-threatening allergic reaction.
Brazil's top court opens session to decide on abortion decriminalization
The Centers for Disease Control and Prevention (CDC) has recommended that pregnant women get vaccinated against respiratory syncytial virus (RSV) to protect their newborns. The vaccine should be given between 32 and 36 weeks of pregnancy.
.png)
.png)
DA says it needs more research before deciding to approve nasal spray to treat dangerous allergies
September 23, 2023.png)
.png)
.png)
